---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-020883"
form_type: "8-K"
ticker: "PCSA"
cik: "0001533743"
company_name: "Processa Pharmaceuticals, Inc."
filed_at: "2024-05-21T23:59:59+00:00"
generated_at: "2026-06-01T10:48:40.978209+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Processa enters ATM equity agreement to sell up to $2.4M in common stock

## Summary
- Sales agreement with A.G.P./Alliance Global Partners for at-the-market offering of up to $2.4 million.
- Sales Agent receives up to 3% commission on gross proceeds from shares sold.
- Net proceeds to fund R&D for oncology drug candidates and working capital.
- Registration statement filed on May 21, 2024 but not yet effective.
- Company is not obligated to sell any shares under the agreement.

## SEC filing metadata
- accession: 0001493152-24-020883
- form_type: 8-K
- ticker: PCSA
- cik: 0001533743
- company_name: Processa Pharmaceuticals, Inc.
- filed_at: 2024-05-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1533743/000149315224020883/0001493152-24-020883-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1533743/000149315224020883/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-020883
- JSON: https://secwatch.observer/filing/0001493152-24-020883.json
- Plain text: https://secwatch.observer/filing/0001493152-24-020883.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.